CL2017002420A1 - Detección de lesión cerebral - Google Patents
Detección de lesión cerebralInfo
- Publication number
- CL2017002420A1 CL2017002420A1 CL2017002420A CL2017002420A CL2017002420A1 CL 2017002420 A1 CL2017002420 A1 CL 2017002420A1 CL 2017002420 A CL2017002420 A CL 2017002420A CL 2017002420 A CL2017002420 A CL 2017002420A CL 2017002420 A1 CL2017002420 A1 CL 2017002420A1
- Authority
- CL
- Chile
- Prior art keywords
- tbi
- brain injury
- victims
- cte
- neuronal damage
- Prior art date
Links
- 208000029028 brain injury Diseases 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 title 1
- 208000030886 Traumatic Brain injury Diseases 0.000 abstract 4
- 230000009529 traumatic brain injury Effects 0.000 abstract 4
- 208000004051 Chronic Traumatic Encephalopathy Diseases 0.000 abstract 3
- 208000017004 dementia pugilistica Diseases 0.000 abstract 3
- 230000003961 neuronal insult Effects 0.000 abstract 2
- 230000003542 behavioural effect Effects 0.000 abstract 1
- 230000005779 cell damage Effects 0.000 abstract 1
- 208000037887 cell injury Diseases 0.000 abstract 1
- 230000008809 cell oxidative stress Effects 0.000 abstract 1
- 230000002596 correlated effect Effects 0.000 abstract 1
- 238000011156 evaluation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 108091027963 non-coding RNA Proteins 0.000 abstract 1
- 102000042567 non-coding RNA Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/669,454 US9605315B2 (en) | 2014-03-26 | 2015-03-26 | Detection of traumatic brain injury |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2017002420A1 true CL2017002420A1 (es) | 2018-07-13 |
Family
ID=56979279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2017002420A CL2017002420A1 (es) | 2015-03-26 | 2017-09-26 | Detección de lesión cerebral |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US9605315B2 (OSRAM) |
| EP (1) | EP3274008B1 (OSRAM) |
| JP (1) | JP2018518147A (OSRAM) |
| CN (1) | CN107427614B (OSRAM) |
| AU (2) | AU2015387481B2 (OSRAM) |
| CA (1) | CA2976347A1 (OSRAM) |
| CL (1) | CL2017002420A1 (OSRAM) |
| ES (1) | ES3014311T3 (OSRAM) |
| IL (1) | IL253889A0 (OSRAM) |
| SG (1) | SG11201707332XA (OSRAM) |
| WO (1) | WO2016153549A1 (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105861712B (zh) | 2011-04-18 | 2021-05-14 | 迪阿米尔有限责任公司 | 使用来自体液的miRNA来早期检测和监控轻度认知障碍(MCI)和阿尔茨海默病(AD)的方法 |
| ES2813699T3 (es) | 2013-11-18 | 2021-03-24 | Diamir Llc | Métodos de uso de miARN de fluidos corporales para la detección y monitoreo de la enfermedad de Parkinson (PD) |
| WO2017087726A1 (en) * | 2015-11-18 | 2017-05-26 | Dignity Health | Methods of diagnosing epilepsy |
| US10975436B2 (en) | 2016-01-05 | 2021-04-13 | Diamir, Llc | Methods of using miRNA from bodily fluids for diagnosis and monitoring of neurodevelopmental disorders |
| GB201603967D0 (en) * | 2016-03-08 | 2016-04-20 | Univ Birmingham | Biomarkers of traumatic brain injury |
| EP3433381B1 (en) | 2016-03-21 | 2024-07-24 | Diamir, LLC | Methods of using mirnas from bodily fluids for detection and differentiation of neurodegenerative diseases |
| CN108300788B (zh) * | 2017-01-13 | 2021-07-09 | 中国人民解放军南京军区南京总医院 | 一种用于检测轻型脑外伤的微小核糖核酸组合及其应用 |
| WO2018175941A1 (en) * | 2017-03-23 | 2018-09-27 | Quadrant Biosciences Inc. | Analysis and prediction of traumatic brain injury and concusion symptoms |
| US10781487B2 (en) | 2017-07-24 | 2020-09-22 | Diamir, Llc | miRNA-based methods for detecting and monitoring aging |
| CN112424606B9 (zh) * | 2018-05-31 | 2025-03-07 | 阿米达斯公司 | 用于检测创伤性脑损伤的组合物和方法 |
| WO2025039033A1 (en) * | 2023-08-21 | 2025-02-27 | Glia Diagnostics Pty Ltd | Methods and reagents for diagnosis and/or prognosis of traumatic brain injury |
| CN118314963B (zh) * | 2023-11-13 | 2024-10-29 | 中国人民解放军空军特色医学中心 | 一种基于lasso回归的血小板储存损伤风险预测模型及其构建方法和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL145209A0 (en) * | 2000-09-06 | 2002-06-30 | Pfizer Prod Inc | Pharmaceutical combinations for the treatment of stroke and traumatic brain injury |
| AU2003237379A1 (en) * | 2002-06-10 | 2003-12-22 | Oklahoma Medical Research Foundation | A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| US20110111976A1 (en) * | 2008-04-25 | 2011-05-12 | Merck Sharp & Dohme Corp. | Microrna biomarkers of tissue injury |
| JP5909447B2 (ja) * | 2009-09-14 | 2016-04-26 | バンヤン・バイオマーカーズ・インコーポレーテッド | ニューロン損傷診断のためのマイクロｒｎａ、自己抗体およびタンパク質マーカー |
| WO2011149354A1 (en) * | 2010-05-28 | 2011-12-01 | Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg | Mirnas involved in the blood brain barrier function |
| TW201231671A (en) * | 2011-01-28 | 2012-08-01 | Univ Kaohsiung Medical | Method and kit for in vitro diagnosis of atherosclerosis |
| WO2013032962A2 (en) | 2011-08-28 | 2013-03-07 | The Board Of Trustees Of The Leland Stanford Junior University | Micro rnas to treat stroke, ischemic brain injury, traumatic brain injury, and neurodegenerative disease |
| WO2013036993A1 (en) * | 2011-09-13 | 2013-03-21 | Commonwealth Scientific And Industrial Research Organisation | Detection of viral infection |
| WO2013122778A1 (en) * | 2012-02-15 | 2013-08-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of treating and preventing diseases and disorders of the central nervous system |
| US9101580B2 (en) * | 2012-12-18 | 2015-08-11 | Matthew Bennett | Compositions and methods for treating traumatic brain injury |
-
2015
- 2015-03-26 US US14/669,454 patent/US9605315B2/en active Active
- 2015-09-22 ES ES15886700T patent/ES3014311T3/es active Active
- 2015-09-22 AU AU2015387481A patent/AU2015387481B2/en active Active
- 2015-09-22 CA CA2976347A patent/CA2976347A1/en active Pending
- 2015-09-22 WO PCT/US2015/051518 patent/WO2016153549A1/en not_active Ceased
- 2015-09-22 CN CN201580077882.4A patent/CN107427614B/zh active Active
- 2015-09-22 JP JP2017541658A patent/JP2018518147A/ja active Pending
- 2015-09-22 SG SG11201707332XA patent/SG11201707332XA/en unknown
- 2015-09-22 EP EP15886700.2A patent/EP3274008B1/en active Active
-
2017
- 2017-02-14 US US15/432,172 patent/US10202649B2/en active Active
- 2017-08-07 IL IL253889A patent/IL253889A0/en unknown
- 2017-09-26 CL CL2017002420A patent/CL2017002420A1/es unknown
-
2018
- 2018-12-17 US US16/222,864 patent/US10815529B2/en active Active
-
2021
- 2021-10-29 AU AU2021258088A patent/AU2021258088B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016153549A1 (en) | 2016-09-29 |
| SG11201707332XA (en) | 2017-10-30 |
| EP3274008A4 (en) | 2018-10-24 |
| ES3014311T3 (en) | 2025-04-21 |
| US10815529B2 (en) | 2020-10-27 |
| US10202649B2 (en) | 2019-02-12 |
| EP3274008B1 (en) | 2024-12-04 |
| EP3274008A1 (en) | 2018-01-31 |
| US20170268058A1 (en) | 2017-09-21 |
| AU2015387481B2 (en) | 2021-08-05 |
| US20190352716A1 (en) | 2019-11-21 |
| US20150344954A1 (en) | 2015-12-03 |
| AU2015387481A1 (en) | 2017-08-03 |
| AU2021258088B2 (en) | 2024-11-28 |
| CN107427614A (zh) | 2017-12-01 |
| IL253889A0 (en) | 2017-10-31 |
| US9605315B2 (en) | 2017-03-28 |
| JP2018518147A (ja) | 2018-07-12 |
| AU2021258088A1 (en) | 2021-11-25 |
| CN107427614B (zh) | 2021-10-15 |
| EP3274008C0 (en) | 2024-12-04 |
| CA2976347A1 (en) | 2016-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2017002420A1 (es) | Detección de lesión cerebral | |
| MX2019003474A (es) | Metodos mejorados para evaluar el estado de la proteina acidica fibrilar glial (gfap) en muestras de pacientes. | |
| ECSP19044183A (es) | (aza)indol-, benzotiofen, y benzofuran-3-sulfonamidas | |
| PE20181131A1 (es) | COMPOSICIONES DE ARNi PARA LIGANDO 1 DE MUERTE CELULAR PROGRAMADA 1 (PD-L1) Y METODOS DE USO DE LAS MISMAS | |
| CO2019005236A2 (es) | Métodos para tratar afecciones inflamatorias | |
| EA201792642A1 (ru) | Способы диагностики для т-клеточной терапии | |
| MX2016007492A (es) | Métodos y composiciones para el tratamiento de afecciones asociadas con el envejecimiento. | |
| MX2019008380A (es) | Composiciones de arni contra el componente c5 del complemento y metodos para su uso. | |
| MX2021014709A (es) | Composiciones para usarse en el incremento de los niveles de globulos rojos y el tratamiento de enfermedad de celulas falciformes. | |
| CO2017004715A2 (es) | Métodos y formulaciones para tratar enfermedades vasculares de los ojos | |
| HK1259386A1 (zh) | 与白介素-33 (il-33)介导的疾病有关的生物标志物及其用途 | |
| CL2017002825A1 (es) | Formulaciones de tpp1 y métodos para tratar la enfermedad de cln2 | |
| EP4374873A3 (en) | Methods for treating or preventing opthalmological conditions | |
| CO2017000346A2 (es) | Anticuerpos de unión a protofibrillas aβ | |
| HUE053968T2 (hu) | Triazinon vázzal és imidazo-pirazinon vázzal rendelkezõ PDE9 inhibitorok perifériás betegségek kezelésére | |
| CR20170259A (es) | Terapias de envenenamiento y composiciones farmacéuticas, sistemas y equipos relacionados | |
| ECSP14017586A (es) | Derivados de tetrahidro-quinazolinona | |
| MX2016010328A (es) | Tratamiento con halogeno de ataque cardiaco y lesion isquemica. | |
| CY1120139T1 (el) | Χρηση κλαδριβινης για αντιμετωπιση οπτικης νευρομυελιτιδας | |
| MX2015012315A (es) | Uso de levocetirizina y montelukast en el tratamiento de lesion traumatica. | |
| MX2018000528A (es) | Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo. | |
| BR112017019841A2 (pt) | técnica de análise de amostra de tecido | |
| PH12016502403B1 (en) | Compositions for anti-inflammatory, antioxidant effects and improved respiratory function by specific histone deacetylase inhibition | |
| CL2017002967A1 (es) | Beta-caseinas a2 y capacidad antioxidante. | |
| MX381982B (es) | Polifenoles de cacao y fibra dietética soluble para usar en el tratamiento o la prevención de trastornos asociados con una cantidad por encima de lo normal de granulocitos en un tejido. |